Updating!
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Moolec Science SA
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001213900-24-080686 (33 Act) Size: KB |
Sep-20-2024 | 241313721 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-078663 (34 Act) Size: KB |
Sep-13-2024 | 241298708 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-067099 (34 Act) Size: KB |
Aug-09-2024 | 241192175 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-061234 (34 Act) Size: KB |
Jul-15-2024 | 241116237 |
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001213900-24-058287 (33 Act) Size: KB |
Jul-02-2024 | 241093482 |
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001213900-24-058284 (33 Act) Size: KB |
Jul-02-2024 | 241093474 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-057118 (34 Act) Size: KB |
Jun-28-2024 | 241084812 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-048263 (34 Act) Size: KB |
May-31-2024 | 241008328 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-046541 (34 Act) Size: KB |
May-24-2024 | 24982972 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-037854 (34 Act) Size: KB |
Apr-30-2024 | 24897548 |
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001213900-24-037253 (33 Act) Size: KB |
Apr-29-2024 | 24892245 |
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001213900-24-037245 (33 Act) Size: KB |
Apr-29-2024 | 24892173 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-035133 (34 Act) Size: KB |
Apr-23-2024 | 24862802 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-034133 (34 Act) Size: KB |
Apr-18-2024 | 24854707 |
SC 13D | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001213900-24-033865 (34 Act) Size: KB |
Apr-17-2024 | 24851942 |
SC 13D/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001104659-24-045955 (34 Act) Size: KB |
Apr-10-2024 | 24836987 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-021781 (34 Act) Size: KB |
Mar-12-2024 | 24741736 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-016873 (34 Act) Size: KB |
Feb-26-2024 | 24676836 |
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001213900-24-014480 (33 Act) Size: KB |
Feb-15-2024 | 24643367 |
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001213900-24-014478 (33 Act) Size: KB |
Feb-15-2024 | 24643363 |
Recent 20 filings. View all Moolec Science SA filings
Thanks I look forward to using the product to improve my skin tone
Very good communication and delivery made within the timeframe I was advised of
Huge help thank you for your help .. y'all make it so much easier
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by